Back to search

Article

Treatment of a metabolic liver disease by <i>in vivo</i> prime editing in mice

2021-08-17

Abstract excerpt

Prime editing is a highly versatile CRISPR-based genome editing technology with the potential to correct the vast majority of pathogenic mutations (1) . However, correction of a disease phenotype in vivo in somatic tissues has not been demonstrated thus far. Here, we establish proof-of-concept for in vivo prime editing and repair the metabolic liver disease phenylketonuria (PKU) in mice. We first developed a si...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1ce589f6-448b-5e64-bedf-ab9dd42d4d5d
DOI
10.1101/2021.08.17.456632
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treatment of a metabolic liver disease by <i>in vivo</i> prime editing in miceDOI 10.1101/2021.08.17.456632
Select a neighboring publication to make it the new centre.